Mitochondria-based photodynamic anti-cancer therapy

Advanced Drug Delivery Reviews

Volumn 49, Issue 1-2, 2001, Pages 71-86

  Morgan, Janet ^a   Oseroff, Allan R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Binding site; Mitochondrial damage; Photosensitizer; Phototoxicity; Subcellular localization; Target

Indexed keywords

BIOCHEMICAL ENGINEERING; MUTAGENESIS; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; TUMORS;

CELLULAR TARGETS;

BIOMEDICAL ENGINEERING;

AMINOLEVULINIC ACID; BENZODIAZEPINE RECEPTOR; CARBOCYANINE; CARDIOLIPIN; CHALCOGENAPYRYLIUM DYE; LIPID; M PROTEIN; OXAZINE DERIVATIVE; PHENOTHIAZINE DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; PYRONINE; RHODAMINE 123; THIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; BINDING AFFINITY; CANCER; CANCER RADIOTHERAPY; CELL DEATH; CELL ISOLATION; CELL KILLING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG TARGETING; HUMAN; MITOCHONDRION; NECROSIS; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOREACTIVATION; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; REVIEW; THERAPY RESISTANCE;

EID: 0035797106     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00126-0     Document Type: Article

References (147)

1. How does photodynamic therapy work?
2. Photodynamic therapy
3. Lasers and photodynamic therapy
4. Agents used in photodynamic therapy
5. 5-Aminolevulinic acid-based photodynamic therapy - Clinical research and future challenges
6. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on drugs in culture
7. 5-Aminolevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line
8. Biosynthesis of δ-aminolevulinic acid and the regulation of heme formation by immature erythroid cells in man
9. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model
10. Localization and efficacy analysis of the phototherapeutic Lutetium Texaphyrin (PC1-0123) in the murine EMT6 sarcoma model
11. Differential retention of rhodamine 123 by avian sarcoma virus-induced glioma and normal tissue of the rat in vivo
12. Hematoporphyrin derivative-induced photosensitivity of mitochondrial succinate dehydrogenase and selected cytosolic enzymes of R323OAC mammary adenocarcinomas
13. Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo
14. In vitro photosensitization of tumour cell enzymes by Photofrin II administered in vivo
15. Structure and biodistribution relationships of photodynamic sensitizers
16. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines
17. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX
18. Effect of mammalian cell differentiation on response to exogenous 5-aminolevulinic acid
19. Cell-type-specific protoporphyrin IX metabolism in human bladder cancer in vitro
20. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives
21. Selective photosensitization of mitochondria in HeLa cells by cationic Zn(II) phthalocyanines with lipophilic side-chains
22. Sites of photodamage in vivo and in vitro by a cationic porphyrin
23. Apoptosis or necrosis following photofrin photosensitization: Influence of the incubation protocol
24. Basic mechanisms and subcellular targets related to PDT
25. Mitochondrial membrane potential in living cells
26. The interaction of tumor localizing porphyrins with collagen and elastin
27. The binding of tumor localizing porphyrins to a fibrin matrix and their effects following photoirradiation
28. An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins
29. Sites and efficacy of photodamage by tin etiopurpurin in vitro using different delivery systems
30. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles
31. Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle
32. 2+ transport in monkey kidney cells (CV-1)
33. Photodynamic tumor therapy: Mitochondrial benzodiazepine receptors as a therapeutic target
34. Time-resolved fluorescence spectroscopy and intracellular imaging of disulphonated aluminium phthalocyanine
35. The subcellular localization of Zn(ii) phthalocyanines and their redistribution on exposure to light
36. Photosensitization, uptake, and retention of phenoxazine Nile Blue derivatives in human bladder carcinoma cells
37. 6
38. Sulphonated aluminium phthalocyanines as sensitizers for photochemotherapy. Effects of small light doses on localization, dye fluorescence and photosensitivity in V79 cells
39. Comparison of photodynamic targets in a carcinoma cell line and its mitochondrial DNA-deficient derivative
40. Mitochondria in cancer cells as targets of photodynamic therapy
41. Mitochondrial photosensitization by Photofrin II
42. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo
43. Prevention of Apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
44. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
45. Photodynamic therapy: A mitochondrial inducer of apoptosis
46. Rapid cytochrome c release, activation of caspases 3, 6,7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy
47. The role of subcellular localization in initiation of apoptosis by photodynamic therapy
48. Mitochondrial photodamage and PDT-induced apoptosis
49. Determinants of the apoptotic response to lysosomal photodamage
50. Subcellular localization of porphyrins using confocal laser scanning microscopy
51. The binding characteristics and intracellular localization of temoporfin (mTHPC) in myeloid leukemia cells: Phototoxicity and mitochondrial damage
52. Selective photosensitization of mitochondria in HeLa cells by cationic Zn (II) phthalocyanines with lipophilic side-chains
53. Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells
54. Interstitial laser photochemotheraphy of rhodamine-123-sensitized rat glioma
55. Cationic triarylmethane photosensitizers for selective photochemotherapy: Victoria Blue-BO, Victoria Blue-R and Malachite Green
56. Photosensitizing effects of the tricyclic heteroaromatic cationic dyes Pyronin Y and Toluide Blue O (Tolonium Chloride)
57. Chalcogenapyrylium dyes as photochemotherapeutic agents. 2. Tumor uptake, mitochondrial targeting, and singlet-oxygen-induced inhibition of cytochrome c oxidase
58. Novel red absorbing benzo[a]phenoxazinium and benzo[a]phenothiazinium photosensitizers: In vitro evaluation
59. Strategies for selective cancer photochemotherapy: Antibody-targetted and selective carcinoma cell photolysis
60. Morphological aspects of an experimental tumour photosensitized with a meso-substituted cationic porphyrin
61. Increased Rhodamine 123 uptake by carcinoma cells
62. Use of nonyl acridine orange and rhodamine 123 to follow biosynthesis and functional assembly of mitochondrial membrane during L1210 cell cycle
63. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of Rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells
64. Multiple modality treatment of carcinoma cells with Pt(Rh-123)2 plus light
65. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: Evidence for mitochondrial involvement
66. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor δ-aminolevulinic acid (ALA)
67. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats
68. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation
69. In vivo kinetics and spectra of 5-amino levulinic acid-induced fluorescence in an amelanotic melanoma of the hamster
70. Photodynamic therapy using 5-aminolevulinic acid for experimental pancreatic cancer - Prolonged animal survival
71. A regulatory role for porphobilogen deaminase (PBGD) in δ-aminolaevulinic acid (δ-ALA)-induced photosensitization?
72. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase
73. The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells
74. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin
75. The effect of 1,2-diethyl-3-hydroxypyridine-4-one on tissue buildup of protoporphyrin IX: A microscopic quantitative fluorescence study on rat urinary bladder
76. The effect of ALA and radiation on porphyrin/heme biosynthesis in endothelial cells
77. Effect of uva and blue light on porphyrin biosynthesis in epidermal cells
78. Mitochondrial alterations in photodynamic therapy-resistant cells
79. 10N-Nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria
80. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy
81. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor
82. The mitochondrial permeability transition
83. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection
84. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control
85. Selective targeting of bioactive compounds to mitochondria
86. In vitro cellular effects of hematoporphyrin derivative
87. Porphyrin-sensitized photoinactivation of human cells in vitro
88. Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light
89. The photodynamic effects of hematoporphyrin and light on the cytoplasm of human leukemic cells
90. Early biochemical responses to photodynamic therapy monitored by NMR spectroscopy
91. Relationship of mitochondrial function and cellular adenosine triphosphate to hematoporphyrin derivative-induced photosensitization in AC mammary tumors
92. Photodynamic inactivation of selected intracellular enzymes by hematoporphyrin derivative and their relationship to tumor cell viability in vitro
93. Hematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: Impairment of anion translocation
94. Carrier thiols are targets of Photofrin 11 photosensitization of isolated rat liver mitochondria
95. 2+ uptake in liver mitochondria
96. Photodynamic action increases leakage of the mitochondrial electron transport chain
97. Haematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: Inhibition of ADP/ATP translocator
98. Singlet oxygen produced by photodynamic action causes inactivation of the mitochondrial permeability transition pore
99. Photofrin uptake as a function of tumor size and the detection of microscopic nests of tumor cells by Photofrin fluorescence. Mechanistic implications for PDT
100. Parabolic quantitative structure-activity relationships and photodynamic therapy: Application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy
101. In vitro photodynamic effects of lysyl chlorin p6: Cell survival, localization and ultrastructural changes
102. Sites of photodamage induced by photodynamic therapy with a chlorin e6 triacetoxymethyl ester (CAME)
103. Subcellular localization of merocyanine 540(MC540) and induction of apoptosis in murine myeloid leukemia cells
104. Fourier transform multipixel spectroscopy and spectral imaging of protoporphyrin in single melanoma cells
105. Subcellular localization of sulfonated tetraphenyl porphines in colon carcinoma cells by spectrally resolved imaging
106. Photoproduct formation from a zinc benzochlorin Iminium salt detected by fluorescence microscopy
107. Mitochondrial toxicity of cationic photosensitizers for photochemotherapy
108. Mitochondrial toxicity of cationic photosensitizers for photochemotherapy
109. Mechanisms of mitochondrial photosensitization by the cationic dye, N,N'-Bis(2-ethyl-1,3-dioxylene)kryptocyanine (EDKC): Preferential inactivation of complex I in the electron transport chain
110. Basis for the selective cytotoxicity of Rhodamine 123
111. Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria
112. Induction of the respiration-deficient mutation in yeast by various synthetic dyes
113. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts
114. Cytostatic and cytotoxic properties of pyronin Y: Relation to mitochondrial localization of the dye and its interaction with RNA
115. Mitochondria are the functional intracellular target for a photosensitizing boronated porphyrin
116. Mitochondrial DNA determines the cellular response to cancer therapeutic agents
117. Enhanced responsiveness to photodynamic therapy-induced apoptosis after mitochondrial DNA depletion
118. The use of tetrazolium salts to determine sites of damage to the mitochondrial electron transport chain in intact cells following in vitro photodynamic therapy with Photofrin II
119. Characterization of porphyrin interactions with peripheral type benzodiazepine receptors
120. Modification of the photodynamic action of δ-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands
121. A key role for the mitochondrial benzodiazepine receptor in cellular photosensitisation with delta-aminolaevulinic acid
122. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: Correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol
123. Imaging of brain tumors using peripheral benzodiazepine receptor ligands
124. Elevated concentrations of mitochondrial benzodiazepine receptors in ovarian tumors
125. Mitochondrial alterations in photodynamic therapy-resistant cells
126. Investigation of cross resistance to a range of photosensitizers, hyperthermia and ultraviolet light in two radiation-induced fibrosarcoma cell strains resistant to photodynamic therapy in vitro
127. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization
128. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells
129. Mitochondria in chemotherapy-induced apoptosis. A prospective novel target of cancer therapy
130. Distinct stages of cytochrome c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis
131. The photobiology of photodynamic therapy: Cellular targets and mechanisms
132. Light and death: Photons and apoptosis
133. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy
134. Selective light-induced modulation of Bcl-XL and Bax expressions in indocyanine green-loaded U937 cells: Effects of continuous or intermittent photo-sensitization with low IR-light using a 805-nm diode laser
135. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2
136. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection
137. Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity
138. Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity
139. Determinants of the apoptotic response to lysosomal photodamage
140. Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells
141. Ceramide generation in response to photodynamic treatment of L5178Y mouse lymphoma cells
142. Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: Involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2
143. Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells
144. Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light
145. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria
146. Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas